| Abstrakt: |
Keywords: Gatchina; Russia; Basal Ganglia Diseases and Conditions; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Connective Tissue Cells; Enzymes and Coenzymes; Genetic Diseases and Conditions; Genetic Risk; Genetics; Glucocerebrosidase; Health and Medicine; Immunology; Macrophages; Mononuclear Phagocyte System; Movement Disorders; Myeloid Cells; Nervous System Diseases and Conditions; Neurodegenerative Diseases and Conditions; Parkinson's Disease; Parkinsonian Disorders; Phagocytes; Pharmacology; Risk and Prevention; Therapy EN Gatchina Russia Basal Ganglia Diseases and Conditions Brain Diseases and Conditions Central Nervous System Diseases and Conditions Connective Tissue Cells Enzymes and Coenzymes Genetic Diseases and Conditions Genetic Risk Genetics Glucocerebrosidase Health and Medicine Immunology Macrophages Mononuclear Phagocyte System Movement Disorders Myeloid Cells Nervous System Diseases and Conditions Neurodegenerative Diseases and Conditions Parkinson's Disease Parkinsonian Disorders Phagocytes Pharmacology Risk and Prevention Therapy 1987 1987 1 06/26/23 20230627 NES 230627 2023 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in Genetic Diseases and Conditions - Genetic Risk. Gatchina, Russia, Basal Ganglia Diseases and Conditions, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Connective Tissue Cells, Enzymes and Coenzymes, Genetic Diseases and Conditions, Genetic Risk, Genetics, Glucocerebrosidase, Health and Medicine, Immunology, Macrophages, Mononuclear Phagocyte System, Movement Disorders, Myeloid Cells, Nervous System Diseases and Conditions, Neurodegenerative Diseases and Conditions, Parkinson's Disease, Parkinsonian Disorders, Phagocytes, Pharmacology, Risk and Prevention, Therapy. [Extracted from the article] |
